Related Experiment Videos
The rationale for a post-marketing surveillance.
Human Reproduction (Oxford, England)
|January 1, 1987
Summary
Post-marketing surveillance is crucial for patient safety, utilizing various methods like spontaneous reporting and intensive monitoring to detect drug risks. Understanding drug utilization patterns also helps assess the impact of safety warnings on prescribing habits.
Area of Science:
- Pharmacovigilance
- Drug Safety Monitoring
Background:
- Comprehensive drug assessment is not feasible pre-marketing.
- Post-marketing surveillance is vital for patient protection against medication risks.
Purpose of the Study:
- To review methods for post-marketing drug surveillance.
- To highlight the importance of drug utilization data in assessing safety interventions.
Main Methods:
- Spontaneous adverse drug reaction reporting.
- Intensive drug monitoring.
- Health registers for case-control studies.
- Prospective studies.
- Drug utilization studies.
Main Results:
- Spontaneous reporting is quick but suffers from underreporting.
- Intensive monitoring provides high-quality data but is costly.
- Health registers may have diagnostic inaccuracies.
- Prospective studies are informative but time-consuming.
- Drug utilization data estimates patient populations and evaluates warning effectiveness.
Conclusions:
- Multiple methods exist for post-marketing surveillance, each with limitations.
- A combination of methods may be necessary for thorough drug safety assessment.
- Drug utilization data is valuable for evaluating the real-world impact of pharmacovigilance efforts.